Test devices for determination of glucose

• US 5,520,883 A
• Filed: 09/05/1989
• Issued: 05/28/1996
• Est. Priority Date: 11/13/1987
• Status: Expired due to Fees

• Current Assignee: Bayer Corporation (Bayer AG)
• Original Assignee: Miles, Inc. (Bayer AG)
• Inventors: Charlton, Steven C., Hemmes, Paul R., Hatch, Robert P.
• Primary Examiner(s): ALEXANDER, LYLE
• Application Number:
  US07/402,689
• Time in Patent Office: 2,457 Days
• Field of Search: 435/14, 435/28, 422/55-58, 422/61, 436/14, 436/95, 436/164, 436/169, 436/904
• US Class Current: 422/420
• CPC Class Codes: C12Q 1/28 involving peroxidase
• CPC Class Codes: C12Q 1/54 involving glucose or galactose
• CPC Class Codes: G01N 33/725 using peroxidative activity
• CPC Class Codes: Y10S 436/904 Oxidation - reduction indicators
• CPC Class Codes: Y10T 436/104998 Glucose, ketone, nitrate standard or control
• CPC Class Codes: Y10T 436/144444 Glucose

Abstract

Test devices are disclosed which are useful for determining glucose or occult blood comprising a carrier matrix, glucose oxidase, an indicator system and a glucose derivative that upon addition of water hydrolizes to produce glucose.

Claims

1. A test device useful for determining glucose comprising:

a single layer carrier matrix;

a test composition for the determination of glucose incorporated substantially uniformly within the carrier matrix, said composition producing a detectable optical response upon wetting with an aqueous solution of glucose; and

a glucose derivative selected from the group consisting of glucose boronates and glucose borinates, which upon contact with water produces glucose, incorporated in a limited, defined portion of said carrier matrix at a concentration sufficient to provide a detectable optical response in said carrier matrix upon the wetting of said matrix with an aqueous solution.

2. The test device of claim 1, wherein each detectable optical response is color.

3. The test device of claim 1, in which the glucose derivative is incorporated within a plurality of limited, defined portions of said carrier matrix, each glucose derivative being incorporated at a different concentration, and each glucose derivative being incorporated at a concentration sufficient to provide a detectable optical response upon the wetting of said matrix with an aqueous solution.

4. The test device of claim 3, in which the plurality of incorporated glucose derivative concentrations provide clinically significant concentrations of glucose when the carrier matrix is wetted with an aqueous solution.